Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: The original data of oligonucleotide tiller 2 (ot2) exon sequence and the original data of transcriptome sequencing

PROVIDER: PRJNA1234304 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR32643428_1.fastq.gz	Fastqsanger.gz
	SRR32643428_2.fastq.gz	Fastqsanger.gz
	SRR32643429_1.fastq.gz	Fastqsanger.gz
	SRR32643429_2.fastq.gz	Fastqsanger.gz
	SRR32643430_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 10

Similar Datasets

E-MTAB-4270

Project description:Transcription profiling by high throughput sequencing of soybean transcriptome data

2019-05-15 | E-MTAB-4270 | ExpressionAtlas

Project description:Oligo Tiller 2(ot2)Exon sequence raw data

| PRJNA1227237 | ENA

E-GEOD-33294

Project description:Transcriptome sequencing of human hepatocellular carcinoma

2025-01-24 | E-GEOD-33294 | ExpressionAtlas

E-GEOD-58608

Project description:The human skeletal muscle transcriptome assessed with RNA sequencing

2025-01-21 | E-GEOD-58608 | ExpressionAtlas

E-GEOD-36391

Project description:Transcriptome sequencing of Foxtail millet Setaria italica for different tissues

2019-05-15 | E-GEOD-36391 | ExpressionAtlas

Project description:ITS original sequence data

| PRJNA940614 | ENA

Trypanosoma cruzi mini-exon based mRNA amplification technique

Project description:We have developed a method of mRNA amplification based on T7 polymerase, where T7 promoter is attached to a oligonucleotide containing the mini-exon sequence, which will hybridize with cDNA molecules containing the anti-ME sequence

2017-07-31 | GSE94766 | GEO

Long-read transcriptome sequencing reveals abundant promoter diversity in distinct molecular subtypes of gastric cancer

Project description:Deregulated gene expression is a hallmark of cancer, however most studies to date have analyzed short-read RNA-sequencing data with inherent limitations. Here, we combine PacBio long-read isoform sequencing (Iso-Seq) and Illumina paired-end short read RNA sequencing to comprehensively survey the transcriptome of gastric cancer (GC), a leading cause of global cancer mortality. We performed full-length transcriptome analysis across 10 GC cell lines covering four major GC molecular subtypes (chromosomal unstable, Epstein-Barr positive, genome stable and microsatellite unstable). We identify 60,239 non-redundant full-length transcripts, of which >66% are novel compared to current transcriptome databases. Novel isoforms are more likely to be cell-line and subtype specific, expressed at lower levels with larger number of exons, with longer isoform/coding sequence lengths. Most novel isoforms utilize an alternate first exon, and compared to other alternative splicing categories are expressed at higher levels and exhibit higher variability. Collectively, we observe alternate promoter usage in 25% of detected genes, with the majority (84.2%) of known/novel promoter pairs exhibiting potential changes in their coding sequences. Mapping these alternate promoters to TCGA GC samples, we identify several cancer-associated isoforms, including novel variants of oncogenes. Tumor-specific transcript isoforms tend to alter protein coding sequences to a larger extent than other isoforms. Analysis of outcome data suggests that novel isoforms may impart additional prognostic information. Our results provide a rich resource of full-length transcriptome data for deeper studies of GC and other gastrointestinal malignancies.

2021-02-02 | PXD023373 | Pride

E-GEOD-51650

Project description:Expression data from Gdap1 knock-out (deletion of exon 5) mice

2015-07-27 | E-GEOD-51650 | ExpressionAtlas

Mass Spectrometry confirmation of BSA peptide modifications during alkaline sequencing reactions.

Project description:DDA analysis of samples of commercial tryptic peptides of BSA which had been either untreated ("original"), conjugated with the Harnimarta et al sequencing reagent ("conj") or conjugated and exposed to alkaline cleavage conditions ("seq"). Data was searched in Proteome Discoverer 2.5 using a 58.017 Da for the sequencing reagent dynamic modification. The associated BSA2 fasta includes a synthetic sequence to generate in silico tryptic peptides representing the original BSA tryptic peptides lacking a single N-terminal amino acid.

2024-11-13 | MSV000096402 | MassIVE

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data